1. Tanshinone IIA Alleviates the AD Phenotypes in APP and PS1 Transgenic Mice
    Fengling Li et al, 2016, BioMed Research International CrossRef
  2. CX3CL1/CX3CR1 in Alzheimer’s Disease: A Target for Neuroprotection
    Peiqing Chen et al, 2016, BioMed Research International CrossRef
  3. Candesartan ameliorates acute myocardial infarction in rats through inducible nitric oxide synthase, nuclear factor-κB, monocyte chemoattractant protein-1, activator protein-1 and restoration of heat shock protein 72
    XUEFENG LIN et al, 2015 CrossRef
  4. Paeoniflorin ameliorates acute myocardial infarction of rats by inhibiting inflammation and inducible nitric oxide synthase signaling pathways
    CHANG CHEN et al, 2015 CrossRef
  5. Neurogenesis-based epigenetic therapeutics for Alzheimer's disease (Review)
    Xueyuan Li et al, 2016 CrossRef
  6. Protective effect of paeoniflorin on inflammation and apoptosis in the cerebral cortex of a transgenic mouse model of Alzheimer's disease
    XINYI GU et al, 2016 CrossRef
  7. Tanshinone IIA attenuates experimental autoimmune encephalomyelitis in rats
    Jun Yan et al, 2016 CrossRef
  8. Effects and mechanisms of matrix metalloproteinase2 on neural differentiation of induced pluripotent stem cells
    Tao Shu et al, 2018, Brain Research CrossRef
  9. Down regulation of pro-inflammatory pathways by tanshinone IIA and cryptotanshinone in a non-genetic mouse model of Alzheimer’s disease.
    Francesco Maione et al, 2017, Pharmacological Research CrossRef
  10. Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer’s disease
    Ean-Jeong Seo et al, 2017, Pharmacological Research CrossRef
  11. Roles of Nitric Oxide in Treatment of Alzheimer’s Disease
    家卉 王, 2017, AR CrossRef
  12. PXR- and CAR-mediated herbal effect on human diseases
    Chenshu Xu et al, 2016, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
  13. Multiple on-line screening and identification methods for hydroxyl radical scavengers in Yudanshen
    Yu-Qing Wang et al, 2018, Journal of Pharmaceutical and Biomedical Analysis CrossRef
  14. Suppression of MIF-induced neuronal apoptosis may underlie the therapeutic effects of effective components of Fufang Danshen in the treatment of Alzheimer's disease
    Cheng-jie Liang et al, 2018, Acta Pharmacol Sin CrossRef
  15. null
    Antonio Capurso et al, 2018 CrossRef
  16. Tanshinone IIA Attenuates Insulin Like Growth Factor 1 -Induced Cell Proliferation in PC12 Cells through the PI3K/Akt and MEK/ERK Pathways
    Haitao Wang et al, 2018, IJMS CrossRef
  17. Current Trends of Microfluidic Single-Cell Technologies
    Pallavi Shinde et al, 2018, IJMS CrossRef
  18. Protective effects of tanshinone IIA on SH-SY5Y cells against oAβ1–42-induced apoptosis due to prevention of endoplasmic reticulum stress
    Weina Yang et al, 2018, The International Journal of Biochemistry & Cell Biology CrossRef
  19. Danshen: a phytochemical and pharmacological overview.
    Xiao-Dan MEIm et al, 2019, Chin J Nat Med CrossRef
  20. Tanshinones, Critical Pharmacological Components in Salvia miltiorrhiza
    Zhouqian Jiang et al, 2019, Front. Pharmacol. CrossRef
  21. Pharmacognostical Sources of Popular Medicine To Treat Alzheimer’s Disease
    Huba Kalász et al, 2018, TOMCJ CrossRef
  22. Salpratlactones A and B: A Pair of cis–trans Tautomeric Abietanes as Cav3.1 T-Type Calcium Channel Agonists from Salvia prattii
    Fan Xia et al, 2019, Org. Lett. CrossRef
  23. Preliminary Studies on Liquiritin, Deoxyschizandrin, and Tanshinone II A as Potential Anti-Neurodegenerative Disease Agent: Determination by Reverse-Phase Liquid Chromatography in Tianwang Buxin Pills
    Dan Xu et al, 2019, Journal of Analytical Methods in Chemistry CrossRef
  24. Tanshinone IIA attenuates the cerebral ischemic injury-induced increase in levels of GFAP and of caspases-3 and -8
    L. Zhou et al, 2015, Neuroscience CrossRef
  25. The triplet state of tanshinone I and its synergic effect on the phototherapy of cancer cells with curcumin
    Chenchen Zhang et al, 2015, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy CrossRef
  26. null
    Da Cheng Hao et al, 2015 CrossRef
  27. Upregulation effects of Tanshinone IIA on the expressions of NeuN, Nissl body, and IκB and downregulation effects on the expressions of GFAP and NF-κB in the brain tissues of rat models of Alzheimer’s disease
    Jian Li et al, 2015, NeuroReport CrossRef
  28. Comparison of microwave-assisted and heat reflux extraction techniques for the extraction of ten major compounds from Zibu Piyin Recipe using ultra high performance liquid chromatography with tandem mass spectrometry
    Huiying Xu et al, 2016, J. Sep. Science CrossRef
  29. Regulating effect of activated NF-κB on edema induced by traumatic brain injury of rats
    Zi-Ran Wang et al, 2016, Asian Pacific Journal of Tropical Medicine CrossRef
  30. Molecular Signaling Pathways Behind the Biological Effects ofSalviaSpecies Diterpenes in Neuropharmacology and Cardiology
    M. Akaberi et al, 2016, Phytother. Res. CrossRef
  31. Tempol and perindopril protect against lipopolysaccharide-induced cognition impairment and amyloidogenesis by modulating brain-derived neurotropic factor, neuroinflammation and oxido-nitrosative stress
    Mohammed Ragab Abdel-Aziz Ali et al, 2016, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
  32. Multiple on-line HPLC coupled with biochemical detection methods to evaluate bioactive compounds in Danshen injection
    Wen-Bing Peng et al, 2016, Biomedical Chromatography CrossRef
  33. Interactions between inflammation, sex steroids, and Alzheimer’s disease risk factors
    Mariana F. Uchoa et al, 2016, Frontiers in Neuroendocrinology CrossRef
  34. Tanshinone IIA attenuates Aβ25-35-induced spatial memory impairment via upregulating receptors for activated C kinase1 and inhibiting autophagy in hippocampus
    Jiejun Zhu et al, 2017, J Pharm Pharmacol CrossRef
  35. Neuroprotective effects of N-adamantyl-4-methylthiazol-2-amine against amyloid β-induced oxidative stress in mouse hippocampus
    Jiae Kim et al, 2017, Brain Research Bulletin CrossRef
  36. Salvia (Sage): A Review of its Potential Cognitive-Enhancing and Protective Effects.
    Adrian L Lopresti, 2017, Drugs R D CrossRef
  37. Efficacy of Physiologically Active nutrients in the Treatment of Asthenic Disorders in Patients with Chronic Diffuse Liver Diseases
    M. V. Mayevskaya et al, 2019, Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii CrossRef
  38. Tanshinone IIA attenuates Aβ-induced neurotoxicity by down-regulating COX-2 expression and PGE2 synthesis via inactivation of NF-κB pathway in SH-SY5Y cells
    Lijiao Geng et al, 2019, J of Biol Res-Thessaloniki CrossRef
  39. Tanshinone IIA ameliorates cognitive deficits by inhibiting endoplasmic reticulum stress-induced apoptosis in APP/PS1 transgenic mice
    Yingying He et al, 2019, Neurochemistry International CrossRef
  40. Decreased risk of dementia in migraine patients with traditional Chinese medicine use: a population-based cohort study
    Chun-Ting Liu et al, 2017, Oncotarget CrossRef
  41. Tanshinones and mental diseases: from chemistry to medicine
    Sana Javed et al, 2016 CrossRef
  42. Targeting apoptosis and autophagy following spinal cord injury: Therapeutic approaches to polyphenols and candidate phytochemicals
    Fatemeh Abbaszadeh et al, 2020, Pharmacological Research CrossRef
  43. Tanshinone IIA improves diabetes mellitus via the NF-κB-induced AMPK signal pathway.
    Feng-Yi Yuan et al, 2018, Exp Ther Med CrossRef
  44. Identification of New Targets and the Virtual Screening of Lignans against Alzheimer’s Disease
    Mayara dos Santos Maia et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
  45. Pharmacological basis of tanshinone and new insights into tanshinone as a multitarget natural product for multifaceted diseases
    Zhibei Li et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  46. Tanshinone IIA suppresses lipopolysaccharide-induced neuroinflammatory responses through NF-κB/MAPKs signaling pathways in human U87 astrocytoma cells
    Hui Jin et al, 2020, Brain Research Bulletin CrossRef
  47. Salvia miltiorrhiza improves Alzheimer's disease
    Ying Guo et al, 2020 CrossRef
  48. null
    Sarah Benson et al, 2021 CrossRef
  49. Prospective therapeutic potential of Tanshinone IIA: An updated overview.
    Mohammad Azam Ansari et al, 2021, Pharmacol Res CrossRef
  50. Tanshinone IIA: A Review of its Anticancer Effects
    Zhong‐ying Fang et al, 2021, Front. Pharmacol. CrossRef
  51. Leveraging hallmark Alzheimer’s molecular targets using phytoconstituents: Current perspective and emerging trends
    Prajakta A. Dhage et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  52. Tanshinone IIA: A phytochemical as a promising drug candidate for neurodegenerative diseases.
    Lalita Subedi et al, 2021, Pharmacol Res CrossRef
  53. Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis.
    Mariola Herbet, 0 CrossRef
  54. Progress in the Mechanism of Autophagy and Traditional Chinese Medicine Herb Involved in Dementia
    Pengyu Tao et al, 2022, Front. Pharmacol. CrossRef
  55. Polyphenols Targeting Oxidative Stress in Spinal Cord Injury: Current Status and Future Vision
    Fahadul Islam et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
  56. Ethnomedicinal Plants with Protective Effects against Beta-Amyloid Peptide (Aβ)1-42 Indicate Therapeutic Potential in a New In Vivo Model of Alzheimer’s Disease
    Norah A. Althobaiti et al, 2022, Antioxidants CrossRef
  57. Effect of icariin in a rat model of colchicine-induced cognitive deficit: role of β-amyloid proteolytic enzymes
    Eman M. Omar et al, 2022, Nutritional Neuroscience CrossRef
  58. Experimental approaches for altering the expression of Abeta‐degrading enzymes
    David A. Loeffler, 2023, Journal of Neurochemistry CrossRef
  59. MMP2 rs243866 and rs2285053 Polymorphisms and Alzheimer’s Disease Risk in Slovak Caucasian Population
    Agata Ocenasova et al, 2023, Life CrossRef
  60. Therapeutic prospects of naturally occurring p38 MAPK inhibitors tanshinone IIA and pinocembrin for the treatment of SARS‐CoV‐2‐induced CNS complications
    Mehdi Valipour, 2023, Phytotherapy Research CrossRef
  61. Inflammatory signaling pathways in the treatment of Alzheimer's disease with inhibitors, natural products and metabolites (Review)
    Yujia Zheng et al, 2023, Int J Mol Med CrossRef
  62. Study on the role and mechanism of Tan IIA in Alzheimer’s disease based on CREB-BDNF-TrkB pathway
    Xiyong Xiang et al, 2024, Neuroscience Letters CrossRef
  63. Effects of Tanshinone IIA on Cognitive Impairment in Alzheimer’s Disease Rats Via Oxidative Stress, Inflammatory Responses and Apoptosis
    Wujiang Ren et al, 2024, Pharmacognosy Magazine CrossRef
  64. Pharmaceutical Constituents Contents and Deviations in Korean and Chinese Cultivars of Salvia miltiorrhiza Root (Danshen) Followed by Crop Years
    Ye Rim Shin et al, 2024, KJMCS CrossRef
  65. PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative Diseases.
    Anthony Cunha et al, 2021, Pharmaceutics CrossRef
  66. Exploring the Therapeutic Potential of BBB‐Penetrating Phytochemicals With p38 MAPK Modulatory Activity in Addressing Oxidative Stress‐Induced Neurodegenerative Disorders, With a Focus on Alzheimer's Disease
    Asieh Hosseini et al, 2024, Phytotherapy Research CrossRef